Physician profile
James Nigro
NPI 1629043419
$2,605.41
in general payments reported to CMS, 2019-2025
21 companies · $661 in 2025
The $661 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $765 · 2020: $89.28 · 2021: $153 · 2022: $148 · 2023: $287 · 2024: $502 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,450.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $625.01 | 2020-2025 | |
| Pfizer INC. | $286.86 | 2019-2023 | |
| Arcutis Biotherapeutics, INC. | $228.07 | 2024-2025 | Zoryve |
| Genzyme Corporation | $217.51 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $208.40 | 2019-2021 | |
| Galderma Laboratories, L.P. | $140.04 | 2019-2025 | Nemluvio, Twyneo, Oracea |
| Revance Therapeutics, INC. | $135.45 | 2024-2025 | Daxxify |
| Almirall LLC | $128.25 | 2019 | |
| Amgen INC. | $113.16 | 2020-2025 | Otezla, Otezla |
| Allergan, INC. | $107.47 | 2021-2022 | |
| Musculoskeletal Transplant Foundation INC. | $91.54 | 2024 | |
| Ucb, INC. | $62.76 | 2019-2024 | Bimzelx |
| Botanix Sb INC | $47.38 | 2025 | Sofdra |
| Sun Pharmaceutical Industries INC. | $46.85 | 2019-2023 | Ilumya |
| E.R. Squibb & Sons, L.L.C. | $43.91 | 2024-2025 | Sotyktu |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $43.55 | 2021-2023 | Taltz |
| Dermira, INC. | $22.75 | 2019 | |
| Organon LLC | $16.15 | 2025 | Vtama |
| Biofrontera INC. | $14.06 | 2019 | |
| Journey Medical Corporation | $13.76 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Nigro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.